Overview


Cardiovascular surgery treats heart tissue defects. It involves replacing diseased heart valves or grafting heart tissues to repair the damage. There are two types of heart surgery: open and closed. The cardiac surgical device can be used to treat complications of the heart, including congenital and valvar heart diseases. They are used worldwide in the diagnosis and treatment of heart conditions and related disorders. One of the leading causes of pain in medical settings is CVD (cardiovascular disease). These devices also aid in the healing of structural problems within the heart's circulatory systems, including damaged or blocked valves, arteries, and other issues. With heart diseases like stroke and ischemic heart disease (IHD) increasing in prevalence, cardiovascular surgical tools and their impact on heart-related therapy have seen a significant increase in popularity in recent years. Market growth in cardiac surgical devices has been driven by factors such as the rise in cardiac disease, diabetes, and lifestyle disorders. Market growth is further fueled by an increasing number of geriatrics with rising comorbidities, increased sedentary lifestyles, and increased obesity. Cardiopulmonary bypass equipment, perfusion disposables, and beating heart surgery are the main products in this market. Perfectionists operate the cardiopulmonary bypass equipment used in open heart surgeries. Congenital heart defects, heart arrhythmias, coronary disease, congestive cardiac failure, and others are some of the many uses. These devices can be used in hospitals, diagnostic laboratories, and research labs, as well as at home and in ambulatory healthcare. The medical industry uses cardiovascular surgical devices for cardiac surgery.
Heart surgeries include mitral valve replacement and repair. Surgical sealants are used to stop bleeding from surgeries. They can either be applied with a spray gun or in bottles with needles. The number one painkiller in medical practice is still cardiovascular disease. Worldwide, cardiovascular devices are used to diagnose heart disease and treat related problems. These devices are also used to repair heart defects and damaged valves and vessels. Cardiovascular surgical devices have also been brought into the limelight due to stroke and IHD (ischemic heart disease), which are both serious conditions that can cause death and disability. The technology used in the development of cardiology devices has advanced significantly and there are now more indications. Market growth has been driven by the increasing use of cardiology devices for monitoring and therapeutic purposes. Artificial intelligence, a breakthrough in the diagnosis and treatment of certain heart conditions, is proving to be a significant impact on cardiovascular devices.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Cardiovascular Surgical Devices and Technologies Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Cardiovascular Surgical Devices and Technologies Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

• Abbott
• Abiomed inc
• Boston Scientific
• C.R. Bard
• St.Jide medical
• Thoratec Laboratories
• transmedics Inc
• Cook Medical
• Cordis Corp
• Angiodynamics, inc.
(Note: The list of the major players will be updated with the latest market scenario and trends)

By Surgical Devices
• Beating Heart Surgery Systems
• Perfusion Disposables
• CPB Equipment
• Cardiac Ablation Devices
By Cardiac Rhythm Management Devices
• Arrhythmias
• Atrial Fibrillation
• Pacemakers
• Defibrillators
• Electrophysiology Catheters
By Region
North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

• To provide with an exhaustive analysis on the Cardiovascular Surgical Devices and Technologies Market By Surgical Devices, By Cardiac Rhythm Management Devices and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Cardiovascular Surgical Devices and Technologies Market Variables, Trends
    • Scope
        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances
  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Cardiovascular Surgical Devices and Technologies Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Cardiovascular Surgical Devices and Technologies Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Cardiovascular Surgical Devices and Technologies Market, By Surgical Devices Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Beating Heart Surgery Systems
        2. Perfusion Disposables
        3. CPB Equipment
        4. Cardiac Ablation Devices
  • 8.   Cardiovascular Surgical Devices and Technologies Market, By Cardiac Rhythm Management Devices Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Arrhythmias
        2. Atrial Fibrillation
        3. Pacemakers
        4. Defibrillators
        5. Electrophysiology Catheters
  • 9.   North America Cardiovascular Surgical Devices and Technologies Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2024-2032
  • 10.   Latin America Cardiovascular Surgical Devices and Technologies Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2024-2032
  • 11.   Europe Cardiovascular Surgical Devices and Technologies Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Germany
          2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2024-2032
  • 12.   Asia Pacific Cardiovascular Surgical Devices and Technologies Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2024-2032
  • 13.   Middle East and Africa Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2024-2032
  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Abbott
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Abiomed inc
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Boston Scientific
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
          4. C.R. Bard
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
         5. St.Jide medical
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Thoratec Laboratories
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. transmedics Inc
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Cook Medical
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Cordis Corp
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Angiodynamics, inc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients